RPE65 and Abnormal retinal morphology: Voretigene neparvovec is administered via a single subretinal injection, and uses an adeno-associated viral (AAV) vector serotype 2 (AAV2) to restore a functional copy of the RPE65 gene in patients with biallelic mutations in RPE65 causing retinal disease.